These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30963251)

  • 1. An update on the central nervous system manifestations of neurofibromatosis type 1.
    Nix JS; Blakeley J; Rodriguez FJ
    Acta Neuropathol; 2020 Apr; 139(4):625-641. PubMed ID: 30963251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas.
    Helfferich J; Nijmeijer R; Brouwer OF; Boon M; Fock A; Hoving EW; Meijer L; den Dunnen WF; de Bont ES
    Crit Rev Oncol Hematol; 2016 Aug; 104():30-41. PubMed ID: 27263935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.
    Palsgrove DN; Brosnan-Cashman JA; Giannini C; Raghunathan A; Jentoft M; Bettegowda C; Gokden M; Lin D; Yuan M; Lin MT; Heaphy CM; Rodriguez FJ
    Mod Pathol; 2018 Dec; 31(12):1787-1800. PubMed ID: 29973652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
    Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
    Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
    Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
    J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular landscape of glioma in patients with Neurofibromatosis 1.
    D'Angelo F; Ceccarelli M; Tala ; Garofano L; Zhang J; Frattini V; Caruso FP; Lewis G; Alfaro KD; Bauchet L; Berzero G; Cachia D; Cangiano M; Capelle L; de Groot J; DiMeco F; Ducray F; Farah W; Finocchiaro G; Goutagny S; Kamiya-Matsuoka C; Lavarino C; Loiseau H; Lorgis V; Marras CE; McCutcheon I; Nam DH; Ronchi S; Saletti V; Seizeur R; Slopis J; Suñol M; Vandenbos F; Varlet P; Vidaud D; Watts C; Tabar V; Reuss DE; Kim SK; Meyronet D; Mokhtari K; Salvador H; Bhat KP; Eoli M; Sanson M; Lasorella A; Iavarone A
    Nat Med; 2019 Jan; 25(1):176-187. PubMed ID: 30531922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple pilocytic astrocytomas of the cerebellum in a 17-year-old patient with neurofibromatosis type I.
    Dunn IF; Agarwalla PK; Papanastassiou AM; Butler WE; Smith ER
    Childs Nerv Syst; 2007 Oct; 23(10):1191-4. PubMed ID: 17457593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NF1 somatic mutational landscape in sporadic human cancers.
    Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M
    Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas.
    Li J; Perry A; James CD; Gutmann DH
    Neurology; 2001 Apr; 56(7):885-90. PubMed ID: 11294925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
    Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
    Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis type 1: modeling CNS dysfunction.
    Gutmann DH; Parada LF; Silva AJ; Ratner N
    J Neurosci; 2012 Oct; 32(41):14087-93. PubMed ID: 23055477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 1 and high-grade tumors of the central nervous system.
    Rosenfeld A; Listernick R; Charrow J; Goldman S
    Childs Nerv Syst; 2010 May; 26(5):663-7. PubMed ID: 19937438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere alterations in neurofibromatosis type 1-associated solid tumors.
    Rodriguez FJ; Graham MK; Brosnan-Cashman JA; Barber JR; Davis C; Vizcaino MA; Palsgrove DN; Giannini C; Pekmezci M; Dahiya S; Gokden M; Noë M; Wood LD; Pratilas CA; Morris CD; Belzberg A; Blakeley J; Heaphy CM
    Acta Neuropathol Commun; 2019 Aug; 7(1):139. PubMed ID: 31462295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1.
    Tada K; Kochi M; Saya H; Kuratsu J; Shiraishi S; Kamiryo T; Shinojima N; Ushio Y
    Neuro Oncol; 2003 Oct; 5(4):228-34. PubMed ID: 14565158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.
    Gutmann DH; James CD; Poyhonen M; Louis DN; Ferner R; Guha A; Hariharan S; Viskochil D; Perry A
    Neurology; 2003 Nov; 61(10):1397-400. PubMed ID: 14638962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
    Freret ME; Gutmann DH
    J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset.
    Jentoft M; Giannini C; Cen L; Scheithauer BW; Hoesley B; Sarkaria JN; Abell-Aleff PC; Rodriguez EF; Li Y; Rodriguez FJ
    Int J Clin Exp Pathol; 2010 Dec; 4(1):43-57. PubMed ID: 21228927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity.
    Brown JA; Gianino SM; Gutmann DH
    J Neurosci; 2010 Apr; 30(16):5579-89. PubMed ID: 20410111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis type 1 and associated malignancies.
    Yohay K
    Curr Neurol Neurosci Rep; 2009 May; 9(3):247-53. PubMed ID: 19348714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.